SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers faces significant pressure after Novo Nordisk filed a lawsuit for alleged illegal marketing of copycat GLP-1 drugs, prompting Hims to halt sales of its compounded semaglutide pill. The investment community is sharply divided, with some calling it "karma" for IP infringement, while others view it as an "oversold" market overreaction, anticipating a potential short squeeze.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

ELF Beauty is trending after strong earnings and raised guidance were overshadowed by a market reaction many attribute to a recent Super Bowl commercial. The community is actively discussing this perceived overreaction, with many viewing the subsequent dip as a compelling buying opportunity.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is trending due to reports of an SEC review into its accounting practices and the abrupt departures of its CFO and General Counsel, triggering a steep sell-off driven by concerns over financial integrity; however, a vocal part of the community views the severe decline as an oversold opportunity for a rebound.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending after its Q4 earnings report, which, despite a revenue miss, beat EPS estimates and outlined an optimistic outlook for 2026, including the expiration of a value-destructive slab contract and ongoing POSCO partnership discussions. While some in the community view the stock's subsequent dip as a buying opportunity driven by these future catalysts, others remain deeply skeptical about its performance and management.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com's stock is plummeting after issuing weaker-than-expected guidance, sparking widespread investor fears about AI disrupting the traditional software business model. The community is sharply divided, with many fearing obsolescence for SaaS platforms while others view the significant drop as an oversold opportunity.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as the community highlights significant commitments from Tether for advertising and cloud spending, alongside its strategic acquisition of Northern Data, positioning it as a key AI cloud infrastructure player. Discussion is also centering on record-high short interest and the potential for a short squeeze, further amplified by the return of prominent content creators.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending with high volatility as its February 8th PDUFA date for RGX-121 approaches, amidst a recent clinical hold on the therapy and a related program due to a patient's brain tumor, leaving the community sharply divided on whether a significant drop from a Complete Response Letter or a delay is more likely.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending after Morgan Stanley initiated coverage with an Overweight rating, highlighting its strategic pivot to AI data centers, strong power infrastructure, and deals with major hyperscalers like Google. The community is actively discussing the company's significant growth potential, the increasing disconnect from Bitcoin price action, and the possibility of short squeezes.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum (LITE) is currently trending due to a significant earnings beat and exceptionally strong guidance, fueled by robust demand for its optical components essential for AI data center infrastructure. The community is polarized, with bulls highlighting the company's critical role in the AI build-out and massive analyst upgrades, while bears warn of extreme overvaluation and an inevitable market correction.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending after announcing a $5.8 billion all-stock acquisition of Valaris, a move generating buzz as a strategic consolidation to create an offshore drilling leader, aiming to boost cash flow and benefit from an emerging industry upcycle, despite some investor caution regarding potential share dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Conduit Pharmaceuticals Inc. (CDT) tumbled 17% on Wednesday after the company announced that it has entered into a development agreement with privately held animal health company Manoira Corporation.As part of the <a target="_blank" rel="noopener noreferrer nofollow" href="https://s3.amazonaws.com/b2icontent.irpass.cc/2892/rl146071.pdf">agreement</a>, Manoira will evaluate Conduit's clinical-stage candidates AZD1656 and AZD5658 in animal health indications.Manoira will initially focus on the evaluation of AZD1656 in animal Osteoarthritis. Osteoarthritis is a degenerative joint condition in companion animals.The collaboration will help Conduit accelerate its understanding of AZD1656's mechanism of action, safety profile, and potential efficacy across species, while retaining ownership of all data and intellectual property generated for human applications.The partnership, Conduit said, opens potential new revenue streams in the high-growth veterinary market.The parties will determine any future financial benefits and implications upon review of the results of the evaluations and how to proceed as a result of any such findings, Conduit said.Manoira has agreed to fund all the developmental activities of the collaboration, and Conduit has agreed to issue Manoira an up-front consideration of $500,000. Conduit’s consideration will be settled through the issuance of 154,799 shares of common stock at $3.23, or its closing price on Tuesday.On Stocktwits, retail sentiment around CDT stayed unmoved within the ‘extremely bullish’ territory over the past 24 hours while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1264/128;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_04_at_11_58_35_AM_png_7bfe8d0833.webp" alt="CDT's Sentiment Meter and Message Volume as of 12:00 p.m. ET on June 4, 2025 | Source: Stocktwits" width="1264" height="128"><figcaption>CDT's Sentiment Meter and Message Volume as of 12:00 p.m. ET on June 4, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said that they bought the stock during the dip.<stembedurl>https://stocktwits.com/BankingBig/message/616778690</stembedurl>Another sees it rising back to over $10.<stembedurl>https://stocktwits.com/LetsgoDudeszi/message/616768852</stembedurl><a href="https://stocktwits.com/symbol/CDT">CDT stock</a> is down by approximately 98% this year and has lost most of its value over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/lucid-inks-deal-with-graphiteone/chkuKwsRbwU">Lucid Inks Deal With Graphite One To Strengthen Local Graphite Supply Chain: Retail Sees Stock Hitting $3 To $5 In Coming Months</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10

Manoira will initially focus on the evaluation of AZD1656 in animal Osteoarthritis.

Equity

Shares of Conduit Pharmaceuticals Inc. (CDT) dropped 5% on Friday morning after the company’s board <a target="_blank" rel="noopener noreferrer nofollow" href="https://s3.amazonaws.com/b2icontent.irpass.cc/2892/rl145666.pdf">approved</a> a 1-for-15 reverse stock split of its common stock.Earlier, shareholders approved the stock split proposal in a meeting on May 5, leaving it upon the board to determine the exact split ratio.The company said the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20.On May 19 evening, every 15 shares of the firm’s issued and outstanding common stock will be combined into one share, reducing the number of outstanding shares of common stock to about 755,900.The company said no fractional shares will be issued in connection with the split, and those entitled to a fractional share will instead receive a proportional cash payment.Earlier this month, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://s3.amazonaws.com/sec.irpass.cc/2892/0001641172-25-010405.htm">flagged</a> doubts regarding its ability to continue as a going concern for at least the next 12 months.It said management has determined it does not have sufficient cash and other sources of liquidity to fund its current business plan, adding that it had cash and cash equivalents of only $2.1 million as of the end of the first quarter.On Stocktwits, retail sentiment around Conduit Pharmaceuticals remained unmoved within the ‘bearish’ territory over the past 24 hours while message volume remained at ‘extremely low’ levels.<figure class="image"><img style="aspect-ratio:625/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_16_at_10_29_21_AM_png_0ccaac1374.webp" alt="CDT's Sentiment Meter and Message Volume as of 10:30 a.m. ET on May 16, 2025 | Source: Stocktwits" width="625" height="61"><figcaption>CDT's Sentiment Meter and Message Volume as of 10:30 a.m. ET on May 16, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user, however, expressed skepticism about the stock’s performance.<stembedurl>https://stocktwits.com/rkfrkf/message/614872963</stembedurl>The shares closed at over $1 last in early April.<a href="https://stocktwits.com/symbol/CDT">CDT stock</a> is down 95% this year and has lost nearly all of its value over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/trump-says-tariff-deals-with-other-countries-in-two-three-weeks/chiwIazRbnt">Trump Says Tariff Deals With Other Nations To Be Set Within 2 To 3 Weeks: ‘I Think We’re Going To Be Very Fair’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic

The company said that the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20. 

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic 

The company said that the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20. 


CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

CDT Equity Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

CDT
Conduit Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CDT News

CDTConduit Pharmaceuticals Inc